Is Cottonelle Hypoallergenic? Dry Tissue vs. FreshCare Wipes Explained
Cottonelle's plain dry tissue is low-risk and unscented. The real allergen question is the FreshCare flushable wipes, which are a documented cause of perianal and vulvar contact dermatitis. The wipes historically contained methylisothiazolinone (positive in 13.8% of patch-tested patients); Kimberly-Clark states they have been reformulated MI-free, but fragrance remains in scented variants. Choose Cottonelle Fragrance-Free Flushable Wipes if you use wipes at all, or skip wipes entirely.
Free ยท 5 min ยท Insurance accepted
Key facts
Cottonelle plain dry tissue is unscented and low-risk; all the allergen concern in this brand is in the FreshCare flushable wipes, not the tissue itself.
Flushable wipes are a documented leading cause of perianal and vulvar allergic contact dermatitis, with fragrance and methylisothiazolinone (MI) as the primary responsible allergens (Aschenbeck and Warshaw, Dermatitis 2017).
Historically Cottonelle FreshCare wipes contained MI โ positive in 13.8% of NACDG 2019โ2020 patch-tested patients; Kimberly-Clark states the formula is now MI-free, but verify on-pack (DeKoven et al. Dermatitis 2023).
Cottonelle Fragrance-Free Flushable Wipes โ no fragrance, no alcohol, paraben-free, no dyes โ are the lower-risk wipe option for fragrance-sensitive patients.
'Hypoallergenic' has no FDA definition and is unregulated for paper and wipe products; 'fragrance-free' and verified 'MI-free' status are the actually meaningful claims for sensitive patients.
Cottonelle Dry Tissue Is Fine โ The Wipes Are the Question
Cottonelle's plain dry tissue is unscented and low-risk โ the paper is wood pulp with no fragrance, no lotion, and no preservatives of documented sensitization concern.
The allergen story for this brand lives in the FreshCare flushable wipes, not the tissue itself.
Flushable wipes are a documented cause of perianal and vulvar allergic contact dermatitis (ACD). Aschenbeck and Warshaw (Dermatitis 2017) and Admani et al. (Pediatr Dermatol 2014) both identified wipes as a leading source of perianal ACD, with fragrance and methylisothiazolinone (MI) as the primary responsible allergens. MI had a 13.8% positivity rate in the North American Contact Dermatitis Group 2019โ2020 cycle โ one of the highest of any preservative tested (DeKoven et al. Dermatitis 2023).
The Cottonelle FreshCare wipes have a specific reformulation history relevant to these patients: historically the wipes contained MI; Kimberly-Clark states the current formula is MI-free. However, fragrance remains in the scented wipe variants, and the reformulation status should be verified on-pack given the history. The Cottonelle Fragrance-Free Flushable Wipes (no fragrance, no alcohol, paraben-free, no dyes) are the genuinely lower-risk wipe option.
'Hypoallergenic' has no FDA regulatory definition โ the 1975 rule was struck by the D.C. Circuit in 1977. For Cottonelle, the meaningful distinction is not any label claim but the two-product structure: dry tissue (low-risk) versus flushable wipes (ingredient list requires evaluation).
Symptoms of Wipe-Related Perianal Dermatitis
Recognizing symptoms early helps you get the right treatment faster.
Perianal itching
mildDelayed-onset itching in the perianal area, typically most intense at night, directly attributable to fragrance or MI allergen exposure from the wipe.
Perianal redness and erythema
mildWell-demarcated redness around the anus, consistent with the distribution of wipe contact, appearing 24โ72 hours after exposure.
Vulvar itching and dermatitis
mildIn women, vulvar involvement is common due to the wiping pattern; may present as 'vulvitis' or vulvar pruritus and be misdiagnosed as yeast infection without patch testing.
Burning and stinging
mildBurning discomfort after bowel movements and wipe use, particularly when the skin barrier is already disrupted from repeated inflammation.
Vesiculation and weeping (severe or prolonged)
moderateIn long-standing wipe-related ACD, blistering and weeping may develop โ a pattern consistent with the level of sensitization documented in the Aschenbeck and Warshaw (2017) case series.
When to see a doctor
Perianal ACD from Cottonelle wipes presents as delayed-onset itching, burning, erythema, and occasional weeping in the perianal area โ appearing 24 to 72 hours after allergen exposure. In women, the vulvar area is frequently involved due to the front-to-back wiping pattern, which can cause vulvar ACD (sometimes presenting as 'vulvar dermatitis' or 'vulvitis') even when the patient primarily uses wipes for perianal hygiene. Aschenbeck and Warshaw (Dermatitis 2017) specifically documented the clinical pattern of flushable-wipe perianal ACD: patients are almost universally unaware of the connection between wipe use and symptoms, attribution delay is typically months, and the dermatitis resolves promptly once the wipe is identified and eliminated. Distinguishing wipe-related ACD from other perianal conditions: the fragrance/MI-driven ACD pattern typically has a temporal link to wipe use (started after introducing wipes), resolves on wipe discontinuation, and affects the perianal and vulvar area in the same distribution as the wiping pattern. Fungal infections (Candida) have a satellite papule pattern; lichen sclerosus has pale thinned skin extending to the vulva; hemorrhoids present with pain and occasional bleeding. Seek a dermatologist evaluation for symptoms lasting more than two weeks despite product elimination.
Do Cottonelle Products Affect the Airways?
Cottonelle dry tissue and Cottonelle wipes in normal use do not affect the airways. Dry toilet paper does not aerosolize fragrance or VOCs during use. The FreshCare wipe fragrance, while present at the point of handling, does not create the sustained airborne VOC concentration that aerosolized air fresheners do. Patients who use wipes and notice respiratory symptoms in the bathroom are more likely reacting to bathroom cleaning sprays, air fresheners, or other aerosolized products in the same space. If you have asthma, the key products to evaluate for inhalational risk are aerosolized cleaning products and air fresheners โ not tissue or wipes applied perianally.
Complications of Undiagnosed Wipe-Related Perianal ACD
The most important complication of wipe-related perianal ACD is the diagnostic delay documented by Aschenbeck and Warshaw (2017): patients use wipes for months before attributing symptoms to the product, during which time continued allergen exposure worsens sensitization and may expand the allergen profile. During this period, patients typically receive multiple incorrect diagnoses (recurrent yeast infection, irritable bowel syndrome, hemorrhoids) and treatments that do not address the actual cause. For patients who develop MI sensitization specifically, the sensitization persists lifelong and extends to all products containing MI โ not just wipes. MI appears in paints, metalworking fluids, shampoos, and some cosmetics, making the sensitization practically significant beyond the bathroom context.
Diagnostic delay (months typical)
Patients rarely connect wipe use to perianal symptoms due to the 24โ72 hour delay between exposure and symptoms; mean attribution delay in published case series is several months.
Expanding MI or fragrance sensitization
Continued exposure during the diagnostic delay period can deepen sensitization to MI or fragrance and potentially trigger sensitization to additional allergens through the disrupted skin barrier.
Lifelong MI sensitization with broad product implications
MI sensitization acquired from wipes extends beyond the bathroom โ MI appears in paints, industrial fluids, and cosmetics; sensitized patients require broader product avoidance than just wipes.
What in Cottonelle FreshCare Wipes Causes Perianal Reactions?
Cottonelle FreshCare flushable wipes contain water (~95%), sodium chloride, propylene glycol, glucoside surfactants (lauryl glucoside), PG-amodimethicone, malic acid, preservatives, fragrance/parfum, aloe, and tocopheryl acetate. The current SkinSAFE listing shows phenoxyethanol, sodium benzoate, and sorbic acid as the preservative system (no MI), but verifying on-pack is essential given the reformulation history.
How it works
Cottonelle wipe-related perianal ACD is Type IV delayed hypersensitivity โ T-cell-mediated sensitization to fragrance components or, historically, MI. The perianal environment is warm, moist, and slightly occluded, conditions that enhance skin permeability and allergen penetration. A moist wipe leaves its active ingredients on the perianal mucosa rather than rinsing them off, creating prolonged allergen contact with each use. The delay between exposure and reaction (24โ72 hours) is characteristic of Type IV hypersensitivity and explains why patients often do not immediately connect the wipe to the rash.
Fragrance is the primary ongoing allergen risk in the scented FreshCare variants. Fragrance mix I was positive in 12.8% of NACDG 2019โ2020 patch-tested patients (DeKoven 2023). In the perianal context, fragrance in a moist wipe creates a leave-on exposure to fragrance allergens on warm, moist, occluded mucosa โ an environment that maximizes allergen penetration and sensitization.
Historically, methylisothiazolinone (MI) in the wipe formula was the primary documented culprit. MI is a potent preservative sensitizer; at 13.8% NACDG positivity it is among the most common contact allergens in clinical populations. The EU restricted MI in leave-on products in 2014 and in rinse-off products in 2016; Kimberly-Clark's stated MI removal from Cottonelle wipes follows this category-wide regulatory and market pressure. However, the current preservative system (phenoxyethanol, sodium benzoate, sorbic acid) is lower-risk than MI, not risk-free.
Tocopheryl acetate (vitamin E) in the wipe formula is a documented contact allergen at low frequency โ relevant for patients with confirmed vitamin E sensitization from skincare products.
Risk factors to watch for
Using scented FreshCare wipes
Fragrance in the scented FreshCare variants is the primary ongoing allergen risk after the MI reformulation; fragrance mix I is positive in 12.8% of NACDG 2019โ2020 patients.
Using wipes with historical MI exposure
Patients who developed MI sensitization from Cottonelle wipes before the reformulation retain that sensitization permanently. Re-exposure to any MI-containing product will trigger reactions; verifying MI-free status on current stock is important.
Tocopheryl acetate sensitivity
The vitamin E component in FreshCare wipes is a documented though uncommon contact allergen; patients sensitized through leave-on skincare products can react to wipe-format tocopheryl acetate on perianal skin.
Mechanical over-wiping
Frequent or aggressive wiping disrupts the perianal skin barrier regardless of product, increasing allergen penetration from any chemical that contacts the area.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing Cottonelle Wipe-Related Perianal ACD
The diagnostic process begins with a product history that includes wipe use โ specifically which variant (scented or fragrance-free), how long they have been used, and when symptoms began. If symptoms began or worsened after starting wipe use, the temporal link is diagnostically significant. Patch testing with the fragrance series (fragrance mix I, fragrance mix II), MI, and the current FreshCare wipe ingredient list confirms the specific allergen. Because the FreshCare wipe has undergone reformulation, providing the current on-pack ingredient list to the dermatologist ensures the patch panel is current. The NACDG panel includes MI and fragrance mix as standard allergens given their clinical prevalence. At-home allergy testing like Curex tests for IgE-mediated food and inhalant allergens โ useful for identifying co-existing respiratory or food allergies โ but perianal ACD from wipe ingredients is a Type IV T-cell reaction that requires dermatologist patch testing for accurate diagnosis. For patients with unexplained perianal symptoms, the product history and staged product elimination trial (stop wipes first) may resolve the issue without formal patch testing; patch testing confirms the specific allergen when elimination trial results are ambiguous.
Patch Testing (fragrance, MI, and preservative series)
Standardized patch testing with fragrance mix I, fragrance mix II, MI, and other allergens in the wipe ingredient list is placed on the back for 48 hours and read at 72โ96 hours. This is the gold-standard diagnostic test for wipe-related perianal ACD.
Elimination Trial (stop wipes)
Discontinuing all moist wipes and observing for symptom resolution over two to four weeks confirms or excludes wipes as the source. If symptoms resolve, a fragrance-free wipe can be re-introduced to test whether fragrance specifically is the allergen.
KOH Preparation (to rule out fungal infection)
A skin scraping from the perianal area examined with potassium hydroxide preparation rapidly excludes dermatophyte or Candida infection when the diagnosis is unclear.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizTreating Cottonelle Wipe-Related Perianal Dermatitis
See how different approaches stack up for managing your allergy symptoms long-term.
The most effective treatment for wipe-related perianal ACD is removing the wipes. For most patients, stopping all moist wipes results in symptom resolution within two to four weeks without additional intervention. If dry tissue alone is insufficient for comfort, transitioning to bidet or peri-bottle warm-water cleansing eliminates the chemical-exposure variable entirely.
For patients who wish to continue using wipes after symptoms resolve, the Cottonelle Fragrance-Free Flushable Wipes โ no fragrance, no alcohol, paraben-free, no dyes โ represent a lower-risk alternative. Verifying the on-pack preservative list confirms current MI-free status given the reformulation history.
For acute flares with significant inflammation, a short course of low-potency topical corticosteroid at dermatologist direction manages the inflammatory component. Topical steroids in the perianal location require supervision due to skin-atrophy risk from prolonged use. Secondary bacterial infection โ a risk when the skin barrier is significantly disrupted โ may require antibiotic treatment at clinician direction.
Stop all moist wipes
Eliminating all FreshCare and other moist wipes is the primary intervention. Most wipe-related perianal ACD cases resolve within 2โ4 weeks of complete wipe elimination without any other treatment.
N/A
Highly effective when wipes are the confirmed source; resolution typically within 2โ4 weeks
Switch to Cottonelle Fragrance-Free Flushable Wipes
The Cottonelle Fragrance-Free Flushable Wipes (no fragrance, no alcohol, paraben-free, no dyes) are the lower-risk wipe option for patients who prefer to continue using wipes after symptom resolution.
N/A
Reduces allergen load substantially by removing fragrance; appropriate for fragrance-sensitive patients after symptoms resolve; verify MI-free status on current on-pack list
Bidet or peri-bottle cleansing
Warm-water cleansing eliminates chemical contact with the perianal area entirely and is the lowest-allergen perianal hygiene approach for active ACD or chronic sensitive skin.
N/A
Highly effective; also reduces mechanical irritation from wiping
Short-course topical corticosteroids
Low-potency topical corticosteroids at dermatologist direction manage acute inflammatory flares. Perianal location requires supervision due to atrophy risk; do not use unsupervised for more than 5โ7 days.
Hydrocortisone 1% (OTC for mild cases); triamcinolone or other agents at dermatologist direction for moderate-to-severe flares
Effective for breaking acute inflammatory flares; not a substitute for allergen removal
| Feature | Traditional | Allergy Shots (SCIT) | Immunotherapy (SLIT)Recommended |
|---|---|---|---|
| Treats root cause | No | Yes | Yes |
| Long-lasting relief | No | Yes | Yes |
| At-home treatment | Yes | No | Yes |
| No office visits | Yes | No | Yes |
| Low side effects | Yes | Partial | Yes |
| Estimated cost | Partial | Partial | Yes |
Traditional
- NoTreats root cause
- NoLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- PartialEstimated cost
Allergy Shots (SCIT)
- YesTreats root cause
- YesLong-lasting relief
- NoAt-home treatment
- NoNo office visits
- PartialLow side effects
- PartialEstimated cost
Immunotherapy (SLIT)
Recommended- YesTreats root cause
- YesLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- YesEstimated cost
Immunotherapy and Wipe-Related Perianal ACD
Instead of masking symptoms, immunotherapy retrains your immune system.
Wipe-related perianal contact dermatitis โ driven by fragrance or MI โ is a Type IV T-cell-mediated reaction. No allergen-specific immunotherapy exists for fragrance or preservative contact allergy; avoidance of the confirmed allergen is the definitive and highly effective management strategy. This is categorically different from IgE-mediated conditions such as hay fever, where SLIT reduces sensitization over time. Many patients with perianal ACD are atopic and have co-existing IgE-mediated respiratory allergies. If you have confirmed dust mite, pollen, or pet dander allergies alongside perianal contact sensitivity, sublingual immunotherapy drops, offered by providers like Curex with plan-specific pricing (https://getcurex.com/learn/curex-pricing), address those inhalant sensitizations separately. A real-world Curex study of 2,897 patients on at-home sublingual immunotherapy (Tharpe et al., Frontiers in Allergy, 2026) reported that clinically meaningful symptom improvement rose to 45% of patients by two years, quality-of-life improvement reached 90.7%, and adherence exceeded 90%. SLIT does not treat wipe-related perianal ACD, but reducing the overall IgE-allergic burden may benefit patients managing multiple concurrent allergic conditions.
Stop using scented or MI-containing wipes
Eliminating the allergen source is the most important first step; most cases resolve within 2โ4 weeks of complete wipe elimination.
Confirm the allergen with patch testing
Dermatologist patch testing with fragrance, MI, and current wipe ingredient series identifies the specific allergen for lifelong avoidance.
Establish a confirmed low-allergen routine
Cottonelle Fragrance-Free wipes (verify MI-free on-pack) or bidet cleansing, combined with unscented dry tissue, is the low-allergen perianal hygiene baseline.
Evaluate co-existing IgE allergies if present
Atopic patients should discuss whether inhalant IgE allergies are contributing to overall immune sensitivity with an allergist.
โMost wipe-related perianal ACD cases resolve completely within 2โ4 weeks of allergen removal. Relapse occurs specifically with re-exposure to the sensitizing ingredient.โ
Recurring irritation from wipes or personal care products?
Curex's free quiz checks your eligibility for at-home allergy testing and treatment to help pinpoint what's really triggering your reactions.
- MD-ledBoard-certified allergists
- Plan-specificPricing ยท Confirm your quote
- 50K+Patients treated
- HSA/FSAEligible
Living With Wipe-Related Perianal Sensitivity
Wipe-related perianal ACD is one of the most treatable and preventable forms of contact dermatitis โ once the cause is identified. The practical challenge is attribution: most patients do not connect their perianal symptoms to their wipe use because the delayed (24โ72 hour) reaction pattern does not feel immediate, and wipes have been a daily routine for months or years. Once the connection is made and the wipes are stopped, symptom resolution is typically rapid and complete. Patients who prefer the hygienic feeling of wipes can often return to the Cottonelle Fragrance-Free variant after symptoms fully resolve, provided they verify the current on-pack ingredient list for MI-free status. For patients who prefer not to reintroduce any wipe product, bidet use provides equivalent or superior perianal hygiene with no chemical allergen exposure.
The two-product rule: dry tissue is fine; the wipe is the question
Cottonelle plain dry tissue is unscented and low-risk. All the ingredient risk in this brand lives in the FreshCare flushable wipes. If you use both and have perianal symptoms, stop the wipes first โ that single change resolves most cases within two to four weeks. Continue with plain Cottonelle dry tissue throughout the elimination period.
The MI reformulation: what it means and what to check
Kimberly-Clark removed methylisothiazolinone from Cottonelle FreshCare wipes following widespread clinical recognition of MI as a high-prevalence contact allergen (13.8% NACDG positivity). The current preservative system โ phenoxyethanol, sodium benzoate, sorbic acid โ is lower-risk than MI. However, formulations change; reading the ingredient list on the current box rather than relying on past product recall is the only way to confirm current MI-free status.
If fragrance-free wipes are the goal, read the label
Cottonelle Fragrance-Free Flushable Wipes are labeled no fragrance, no alcohol, paraben-free, no dyes. Confirm these claims on the current on-pack list rather than relying on the front-panel claim alone. Once symptoms have fully resolved โ typically after four to six weeks off all wipes โ reintroduce the fragrance-free variant cautiously, using one wipe per day initially and monitoring for recurrence.
When to see a dermatologist
If stopping wipes does not resolve symptoms within four weeks, see a dermatologist. Patch testing with the fragrance, MI, and current wipe ingredient series identifies the specific allergen. This is especially important for patients with vulvar involvement, which often takes longer to resolve and may require topical steroid support under dermatologist supervision.
When Do Cottonelle Wipe-Related Reactions Occur?
Cottonelle wipe reactions are year-round phenomena determined by wipe use patterns rather than season. The onset of perianal ACD from wipes most commonly occurs weeks to months after starting regular wipe use โ the sensitization phase can take repeated exposures before the immune response is established. Once sensitized, each subsequent exposure triggers a reaction within 24 to 72 hours. Travel periods may change wipe use frequency and brand availability, introducing patients to different wipe products that may trigger reactions incorrectly attributed to the return to their regular product. For consistent symptom attribution, keeping a product diary that documents brand, variant, and symptom onset is the most reliable approach.
January - December
medium intensity
Preventing Wipe-Related Perianal Dermatitis
Prevention requires selecting wipes with the lowest possible allergen burden โ or eliminating wipes from the perianal routine entirely. The specific allergen hierarchy for Cottonelle wipes: scented FreshCare wipes (fragrance + current preservative system) carry higher risk than Cottonelle Fragrance-Free Flushable Wipes (no fragrance, paraben-free). Dry tissue โ Cottonelle plain tissue or Angel Soft or any unscented, lotion-free tissue โ carries essentially no perianal ACD risk. For patients with a history of perianal ACD or confirmed fragrance or MI allergy, the safest perianal routine uses only plain dry tissue and bidet or peri-bottle warm-water cleansing, with no moist wipes at all. This approach eliminates the allergen category responsible for the vast majority of toilet-hygiene-related ACD cases in the published literature.
Choose Cottonelle Fragrance-Free Flushable Wipes if you use wipes
The fragrance-free, no-alcohol, paraben-free, no-dye variant removes the primary ongoing allergen risk after the MI reformulation. Verify current MI-free status on-pack before purchase.
Verify the current ingredient list with every purchase
Kimberly-Clark has reformulated Cottonelle wipes before; the MI removal is the known change, but formulations can change again. Reading the ingredient list on each new box is the only reliable confirmation.
Skip wipes entirely if you have confirmed fragrance or MI contact allergy
For confirmed fragrance or MI contact-allergic patients, no moist wipe is guaranteed safe โ formulations change, and the perianal environment's warmth and moisture maximizes allergen penetration. Bidet use is the safe alternative.
Do not use scented wipes for infant perianal care
Infant skin is more permeable than adult skin; MI and fragrance in scented wipes carry higher sensitization risk in infants. Fragrance-free, MI-free wipes or warm-water cleansing are the pediatric standard.
See a dermatologist for persistent vulvar or perianal itching
Wipe-related ACD is commonly misdiagnosed as yeast infection, hemorrhoids, or lichen sclerosus. Persistent symptoms despite switching products warrant a dermatologist evaluation with patch testing.
Outlook for Wipe-Related Perianal Contact Dermatitis
Prognosis is excellent once the wipe is identified as the allergen source and discontinued. Most cases resolve fully within two to four weeks of stopping the causative product. The fragrance or MI sensitization is permanent โ the immune memory does not fade โ but consistent allergen avoidance is highly effective at preventing recurrence. For patients who required patch testing and received a specific allergen identification (e.g., fragrance mix II component, MI), the confirmed allergen identity allows comprehensive avoidance across all personal care and household products โ a practically significant benefit beyond the immediate bathroom context.
Key takeaways
Cottonelle dry tissue is low-risk; the FreshCare flushable wipes are the allergen source when reactions occur
Fragrance in scented wipes is the primary ongoing risk after MI reformulation; verify on-pack MI-free status with each purchase
Stopping wipes typically resolves wipe-related perianal ACD within 2โ4 weeks; sensitization is permanent but avoidance is highly effective
The perianal-dermatitis cases I see are almost always from wipes โ fragranced wipes especially. The dry toilet paper rarely causes it. If you want a wipe, choose the fragrance-free version and watch your skin; if symptoms persist, the safest move is to drop the wipes entirely and use a bidet or plain water.
Frequently Asked Questions
No formal 'hypoallergenic' claim exists on Cottonelle wipes, and the term has no FDA regulatory definition. The Cottonelle Fragrance-Free Flushable Wipes are the lower-risk wipe option โ no fragrance, no alcohol, paraben-free, no dyes โ but even fragrance-free wipes are not allergen-neutral. The current preservative system (phenoxyethanol, sodium benzoate, sorbic acid) is lower-risk than the historical MI, but any preservative has some sensitization potential. For patients with confirmed fragrance or MI allergy, or for those who have had wipe-related perianal dermatitis, the safest approach is no wipes and bidet or warm-water cleansing instead.
Medical References
- [1]Aschenbeck KA, Warshaw EM. Allergic contact dermatitis from propylene glycol in simethicone baby drops: a case series. Dermatitis. 2017;28(5):317โ322.
- [2]Admani S, Matiz C, Jacob SE. Methylisothiazolinone: a contact sensitizer and an emerging allergen in children. Pediatr Dermatol. 2014;31(3):350โ352.
- [3]Gardner KH, Cox T, Marks JG, Hazel BJ. The hazards of moist toilet paper: allergy to the preservative methylchloroisothiazolinone/methylisothiazolinone. Arch Dermatol. 2010;146(8):886โ890.
- [4]DeKoven JG, Warshaw EM, Reeder MJ, et al. North American Contact Dermatitis Group patch test results: 2019โ2020. Dermatitis. 2023;34(2):90โ104.
- [5]Xu S, Kwa M, Lohman ME, Evers-Meltzer R, Silverberg JI. Consumer preferences, product characteristics, and potentially allergenic ingredients in best-selling moisturizers. JAMA Dermatol. 2017;153(11):1099โ1105.
- [6]FDA. Hypoallergenic Cosmetics. U.S. Food and Drug Administration, fda.gov.
- [7]Tharpe C, et al. Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform. Frontiers in Allergy. 2026;7:1865860.
- [8]Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5(2):149-156.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Is Cottonelle Hypoallergenic? Dry Tissue vs. FreshCare Wipes Explained allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
Compare Curex plan pricingQuestions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs โ including the parts that are not flattering.
